Tübingen, Germany

Nigel Horscroft

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2022-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Nigel Horscroft

Introduction

Nigel Horscroft is a notable inventor based in Tübingen, Germany. He has made significant contributions to the field of therapeutic RNA, particularly in the areas of wound healing and liver disease treatment. With a total of 2 patents, his work showcases the potential of RNA technology in medical applications.

Latest Patents

Horscroft's latest patents include innovative approaches to wound healing. One patent focuses on an RNA encoding a therapeutic protein, specifically a collagenase, growth factor, cytokine, receptor, chaperone, or signal transduction inhibitor. This invention aims to promote wound healing through the use of RNA in pharmaceutical compositions and kits. Another patent addresses the treatment or prophylaxis of liver diseases. It provides an RNA encoding various peptides and proteins, including extracellular matrix proteases and growth factors, which can be utilized as a medicament in gene therapy.

Career Highlights

Throughout his career, Nigel Horscroft has worked with prominent companies in the biotechnology sector, including CureVac AG and CureVac SE. His experience in these organizations has allowed him to develop and refine his innovative ideas in RNA technology.

Collaborations

Horscroft has collaborated with several professionals in his field, including Marion Pönisch and Christine Weinl-Tenbruck. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Nigel Horscroft's contributions to RNA technology highlight the potential for innovative treatments in wound healing and liver diseases. His work continues to pave the way for advancements in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…